Examination of the informed consent process as experienced by patients who have undergone a chemoembolization radioembolization or transjugular intrahepatic portosystemic shunt (TIPS) procedure

C
Claire Draucker

Primary Investigator

Overview

The purpose of this study is to describe the experiences of patients providing IC to undergo a de novo TIPS procedure.

Description

The purpose of this study is to describe the experiences of patients providing IC to undergo a de novo TIPS procedure.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    chemoembolization, radioembolization, transjugular intrahepatic portosystemic shunt (TIPS) procedure
  • Age: - 100 Years
  • Gender: All

Inclusion Criteria

1.    Age 18 years and older
2.    Underwent a chemoembolization, radioembolization or de novo TIPS procedure in the prior three months
3.    Participated in the IC process and signed the consent form for the TIPS procedure
4.    Able to read, write, and speak English.
5.     Agrees to complete the Newest Vital Sign (NVS) assessment.

Exclusion Criteria

1.    Family member or healthcare representative provided consent.
2.    Had a revision of the TIPS procedure
3.    Had repeated chemoembolization or radioembolization procedures
4.    Documented history of dementia.

Updated on 09 Mar 2024. Study ID: 1605909865 (IUSCC-0617)

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center